Clinical Trial Update: A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo [Phase 2]

View source ↗

Summary

Phase 2 randomized trial in asthmatic children aged 6 to <12 years comparing budesonide pMDI 160 mcg twice daily with placebo over six weeks. Results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2014-07-21